Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This study will determine whether treatment with AMG 162 can prevent lumbar spine bone loss
in both early and late postmenopausal women with osteopenia, and to further test the safety
and tolerability of AMG 162 in this population.